ARCHIVES

FDA Approves Afinitor-Aromasin Regimen For Advanced HER2-Negative Breast Cancer

This article is from The Cancer Letter archive.

Vol. 35 No. 7 | July 27, 2012

Download PDF Visit The Full Archive

Related Articles

ACS Expresses Concern About “Fletcher Report” On Mammography

May 7, 1993

Women Radiated For Wilms’ At Risk For Complications In Pregnancy, Study Finds

May 31, 2002

ACS Awards Grants Totaling $31.3 Million

January 25, 1985

Drugs and Targets: Akynzeo approved for chemotherapy-related nausea

October 10, 2014

Broder Emerges As National Leader In ASCO Talk, Calls For Faster Reporting Of Clinical

June 2, 1989

In Brief: Melanoma Precursors Consensus Conference Planned, DRCC Board Raps Centers Budget Cut

May 20, 1983